Lucid Diagnostics LUCD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Lucid Diagnostics’s reported figures.
Based on trailing twelve months.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's EBITDA margin?
- Lucid Diagnostics (LUCD) reported EBITDA margin of -942.6% in Q1 2026.
- How has Lucid Diagnostics's EBITDA margin changed year-over-year?
- Lucid Diagnostics's EBITDA margin increased by 16.1% year-over-year, from -1,123% to -942.6%.
- What is the long-term trend for Lucid Diagnostics's EBITDA margin?
- Over 3 years (2022 to 2025), Lucid Diagnostics's EBITDA margin has grown at a -58.4% compound annual growth rate (CAGR), from -14,407.2% to -1,036.3%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.